Makoto Daimon Selected Research

Sexual Infantilism

2/2022

Identification of a homozygous c.1039C>T (p.R347C) variant in CYP17A1 in a 67-year-old female patient with partial 17α-hydroxylase/17,20-lyase deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Daimon Research Topics

Disease

19	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2002
14	Neoplasms (Cancer) 09/2022 - 01/2014
13	Pituitary ACTH Hypersecretion 09/2022 - 01/2014
11	Hypertension (High Blood Pressure) 02/2022 - 05/2002
9	ACTH-Secreting Pituitary Adenoma 09/2022 - 01/2014
8	Insulin Resistance 01/2020 - 05/2005
7	Pituitary Neoplasms (Pituitary Adenoma) 09/2022 - 08/2014
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 06/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 04/2012
6	Glucose Intolerance 05/2012 - 05/2002
5	Cushing Syndrome 09/2022 - 01/2014
4	Diabetes Mellitus 09/2020 - 09/2007
4	Stroke (Strokes) 01/2016 - 03/2008
4	Obesity 01/2014 - 05/2002
3	Overweight 12/2021 - 06/2011
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2018
3	Adenoma (Adenomas) 10/2018 - 08/2014
2	Body Weight (Weight, Body) 01/2021 - 03/2006
2	Inflammation (Inflammations) 01/2021 - 01/2011
2	Ectopic ACTH Syndrome 03/2020 - 01/2014
2	Chronic Renal Insufficiency 01/2020 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2018 - 11/2016
2	Hyperaldosteronism (Conn Syndrome) 01/2016 - 04/2015
2	Acute Intermittent Porphyria (Porphyria, Acute) 08/2013 - 09/2008
2	Cerebral Small Vessel Diseases 01/2011 - 01/2008
2	Dementia (Dementias) 01/2011 - 02/2004
1	Amenorrhea 02/2022
1	Hypokalemia 02/2022
1	Sexual Infantilism 02/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022
1	Abdominal Obesity 12/2021
1	Renal Insufficiency (Renal Failure) 12/2021
1	Anorexia 11/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 03/2020
1	Acromegaly 03/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Polyuria 01/2020
1	Vitamin D Deficiency 01/2020
1	Nephrogenic Diabetes Insipidus 01/2020

Drug/Important Bio-Agent (IBA)

17	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 01/2014
15	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2002
8	Messenger RNA (mRNA)IBA 09/2022 - 08/2014
6	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2022 - 01/2014
6	AdiponectinIBA 01/2015 - 07/2003
5	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 09/2022 - 08/2014
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2021 - 09/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 09/2022 - 01/2015
3	Histone Deacetylase InhibitorsIBA 09/2022 - 01/2015
3	HDL CholesterolIBA 12/2021 - 08/2008
3	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2016
3	AldosteroneIBA 03/2016 - 04/2015
3	ReninIBA 03/2016 - 04/2012
3	CholesterolIBA 01/2016 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 04/2012
3	Retinaldehyde (Retinal)IBA 06/2011 - 08/2006
3	Peptides (Polypeptides)IBA 02/2004 - 05/2003
2	CRF receptor type 2IBA 11/2021 - 11/2017
2	pasireotideIBA 02/2021 - 08/2014
2	trichostatin A (A 300)IBA 01/2021 - 01/2015
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2020 - 08/2014
2	Pharmaceutical PreparationsIBA 02/2020 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2016
2	CalciumIBA 01/2020 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 06/2019 - 08/2012
2	Therapeutic UsesIBA 03/2019 - 01/2018
2	Octreotide (Sandostatin)FDA LinkGeneric 10/2018 - 08/2014
2	Hormones (Hormone)IBA 10/2018 - 03/2016
2	Fatty Acid Binding Protein 3IBA 02/2018 - 01/2014
2	UrocortinsIBA 11/2017 - 11/2014
2	GlucocorticoidsIBA 01/2017 - 01/2016
2	Insulin (Novolin)FDA Link 11/2016 - 01/2016
2	Alanine Transaminase (SGPT)IBA 01/2016 - 08/2009
2	Fibrinogen (Factor I)FDA Link 01/2016 - 01/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2015 - 04/2012
2	AlbuminsIBA 01/2015 - 12/2013
2	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 08/2013 - 09/2008
2	Antihypertensive Agents (Antihypertensives)IBA 04/2012 - 02/2010
2	AntibodiesIBA 02/2004 - 08/2003
2	ChromograninsIBA 02/2004 - 08/2003
1	tubastatin AIBA 09/2022
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 02/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	CRF receptor type 1IBA 11/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2021
1	Xanthine OxidaseIBA 01/2021
1	Histone Deacetylase 1IBA 01/2021
1	FYX-051IBA 01/2021
1	romidepsin (FK228)FDA Link 01/2021
1	Ubiquitin-Specific ProteasesIBA 02/2020
1	EnzymesIBA 02/2020
1	Arginine Vasopressin (Argipressin)IBA 01/2020
1	LithiumIBA 01/2020

Therapy/Procedure

7	Therapeutics 03/2020 - 01/2014
2	Glycemic Control 01/2020 - 02/2003
2	Aftercare (After-Treatment) 12/2019 - 01/2017